Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez, et al.
Cell (2020) Vol. 181, Iss. 7, pp. 1489-1501.e15
Open Access | Times Cited: 3783

Showing 1-25 of 3783 citing articles:

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
Science (2021) Vol. 371, Iss. 6529
Open Access | Times Cited: 2741
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, et al.
The Lancet (2020) Vol. 396, Iss. 10249, pp. 467-478
Open Access | Times Cited: 2505
SARS-CoV-2 vaccines in development
Florian Krammer
Nature (2020) Vol. 586, Iss. 7830, pp. 516-527
Open Access | Times Cited: 2077
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Nina Le Bert, Anthony T. Tan, Kamini Kunasegaran, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 457-462
Open Access | Times Cited: 2061
Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani, Christian Gaebler, Frauke Muecksch, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 437-442
Open Access | Times Cited: 2027
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 158-168.e14
Open Access | Times Cited: 1851
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 996-1012.e19
Open Access | Times Cited: 1808
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1786
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 639-644
Open Access | Times Cited: 1604
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
Divij Mathew, Josephine R. Giles, Amy E. Baxter, et al.
Science (2020) Vol. 369, Iss. 6508
Open Access | Times Cited: 1544
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1452
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 616-622
Open Access | Times Cited: 1442
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1419-1440.e23
Open Access | Times Cited: 1389
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Yanchun Peng, Alexander J. Mentzer, Guihai Liu, et al.
Nature Immunology (2020) Vol. 21, Iss. 11, pp. 1336-1345
Open Access | Times Cited: 1272
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Fengcai Zhu, Xu-Hua Guan, Yu-Hua Li, et al.
The Lancet (2020) Vol. 396, Iss. 10249, pp. 479-488
Open Access | Times Cited: 1234
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
José Mateus, Alba Grifoni, Alison Tarke, et al.
Science (2020) Vol. 370, Iss. 6512, pp. 89-94
Open Access | Times Cited: 1192
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam, Florian Wimmers, Chris Ka Pun Mok, et al.
Science (2020) Vol. 369, Iss. 6508, pp. 1210-1220
Open Access | Times Cited: 1161
Mechanisms of SARS-CoV-2 Transmission and Pathogenesis
Andrew G. Harrison, Lin Tao, Penghua Wang
Trends in Immunology (2020) Vol. 41, Iss. 12, pp. 1100-1115
Open Access | Times Cited: 1114
The T cell immune response against SARS-CoV-2
Paul Moss
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 186-193
Open Access | Times Cited: 1106
Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
Barry M. Popkin, Shufa Du, William D. Green, et al.
Obesity Reviews (2020) Vol. 21, Iss. 11
Open Access | Times Cited: 1070
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1063
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, et al.
New England Journal of Medicine (2020) Vol. 383, Iss. 16, pp. 1544-1555
Open Access | Times Cited: 1054
Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 10, pp. 615-632
Open Access | Times Cited: 1028
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Markus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2384-2393.e12
Open Access | Times Cited: 993
Phenotype and kinetics of SARS-CoV-2–specific T cells in COVID-19 patients with acute respiratory distress syndrome
Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen, et al.
Science Immunology (2020) Vol. 5, Iss. 48
Open Access | Times Cited: 958
Page 1 - Next Page

Scroll to top